Kevin B. Yankton - Sep 30, 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Accounting Officer
Signature
/s/ Alyssa Zhang, Attorney-in-Fact for Kevin B. Yankton
Stock symbol
TWST
Transactions as of
Sep 30, 2022
Transactions value $
-$7,753
Form type
4
Date filed
12/22/2022, 05:20 PM
Previous filing
Aug 19, 2022
Next filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +1.5K +16.8% $0.00 10.4K Sep 30, 2022 Direct F1
transaction TWST Common Stock Tax liability -$7.75K -220 -2.11% $35.24 10.2K Dec 20, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Performance Stock Units ("PSUs"). 1/2 of the PSUs have vested on September 30, 2022 ("Achievement Date"). The remaining half will vest on the one year anniversary of the Achievement Date subject to Mr. Yankton's continuous service.
F2 Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person referenced in Footnote 1. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).